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A six-year-old girl with low-grade fevers and hip pain was referred
to Nuclear Medicine for a three-phase bone scan, to rule out acute
osteomyelitis.
Blood flow and blood pool images were normal. Images at
3 hrs after administration of Tc-99m-HDP are shown on Figures 14.
On delayed images there is abnormal symmetrical blurry ap-
pearance of the proximal, diaphyseal growth plates in both hu-
meri and proximal growth plates of both tibiae. The uptake in the
spine is nonhomogeneous without definite focal abnormalities.
Foci of high tracer uptake are seen in the sternal manubrium and
intertrochanteric area of the right femur.
Focal bony abnormalities could be due to multifocal acute
osteomyelitis, but normal blood flow and blood pool images make
acute osteomyelitis less likely. We thought that the abnormal,
symmetrical appearance of the growth plates, may represent gen-
eralised bone marrow involvement, as in lymphoma.
Jolanta M. Durski1, Clare J. Twist2, Michael Goris3
1Department of Radiology at Kaiser-Permanente Medical Group,
Richmond, CA, USA
2Department of Pediatrics at Stanford University Medical Center,
Stanford, CA, USA
3Division of Nuclear Medicine at Stanford University Medical Center, CA, USA
What is the diagnosis?
Figure 1. Anterior thorax.
Figure 2. Posterior thorax.
Figure 3. Anterior hips and knees.
Figure 4. Posterior hips and knees.
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uation of bone involvement in some studies [8], but less sensi-
tive in others [9, 10]. Bone marrow biopsy is routinely done to
evaluate bone marrow involvement, but it can miss focal dis-
ease. MRI is a sensitive test for bone marrow involvement with
neuroblastoma, but it is less specific than MIBG. The response
of bone and bone marrow lesions to chemotherapy is better
evaluated with MIBG than MRI [11] or bone scans [7].
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Scintigraphic evaluation of bone involvement
in neuroblastoma
Bilateral bone marrow biopsies were positive for neuroblasto-
ma. MRI showed a primary, para-spinal tumour, which was re-
sected. The patient is undergoing chemotherapy and she is await-
ing a stem cell transplant.
Neuroblastoma accounts for 710% of pediatric malignan-
cies and is the most common solid neoplasm outside CNS. It
typically arises in the adrenal medulla or paravertebral regions
of the abdomen or thorax along the sympathetic chain. It
spreads to lymph nodes, cortical bone and bone marrow, liver,
lungs and subcutaneous tissue. On bone scans there is soft
tissue accumulation of the tracer in the primary tumour in 30
85% of the patients. Bone metastases [15] typically present
as multiple areas of increased uptake adjacent to metaphyses
of the long bones. Most often in the proximal humeri, distal
femora and proximal tibiae. Involvement of the skull, vertebrae,
ribs and pelvis is also common. The distribution of bone le-
sions is usually asymmetric. Occasionally metastatic neuroblas-
toma can present as symmetrical loss of normal shape, blurry
appearance of the metaphyseal growth plates of the long
bones. A similar pattern is sometimes seen in acute leukemia
and it may represent diffuse bone marrow involvement. The
metaphyseal uptake as well as occasional lytic bone lesions
may be difficult to evaluate. In one study bone scans were shown
to be less sensitive than radiographs for detection of neuro-
blastoma metastatic to the bones [1], but many other studies
showed that bone scans were much more sensitive than radio-
graphs [35]. Bone scans are routinely done for staging of this
disease. Sometimes a diagnosis of neuroblastoma is made in
children undergoing bone scan for another condition. Fever and
bone pain can be the initial symptoms of neuroblastoma and
a bone scan may be done to evaluate for osteomyelitis [6].
Metaiodobenzylguanidine labelled with I123 or I131 is very useful
for evaluation of soft tissue metastases from neuroblastoma
[7]. It was found to be equally accurate as bone scans, for eval-
The answer to this question is:
diagnosis  neuroblastoma with diffuse bone marrow involvement
